These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 17981670)

  • 61. PPAR-γ activator induces neuroprotection in hypercholesterolemic rats subjected to global cerebral ischemia/reperfusion injury: in vivo and in vitro inhibition of oxidative stress.
    Al Rouq F; El Eter E
    Exp Gerontol; 2014 Mar; 51():1-7. PubMed ID: 24373843
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Peroxisome proliferator-activated receptor gamma agonists as insulin sensitizers: from the discovery to recent progress.
    Cho N; Momose Y
    Curr Top Med Chem; 2008; 8(17):1483-507. PubMed ID: 19075761
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade.
    Yuan Z; Liu Y; Liu Y; Zhang J; Kishimoto C; Wang Y; Ma A; Liu Z
    Heart; 2005 Sep; 91(9):1203-8. PubMed ID: 15774612
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A peroxisome proliferator-activated receptor gamma agonist attenuates neurological deficits following spinal cord ischemia in rats.
    Kim H; Hwang J; Park S; Nahm SF; Min S; Lim C; Park K; Han S
    J Vasc Surg; 2014 Apr; 59(4):1084-9. PubMed ID: 23830318
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Study of new interactions of glitazone's stereoisomers and the endogenous ligand 15d-PGJ2 on six different PPAR gamma proteins.
    Álvarez-Almazán S; Bello M; Tamay-Cach F; Martínez-Archundia M; Alemán-González-Duhart D; Correa-Basurto J; Mendieta-Wejebe JE
    Biochem Pharmacol; 2017 Oct; 142():168-193. PubMed ID: 28716729
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PPAR-gamma agonists as regulators of microglial activation and brain inflammation.
    Bernardo A; Minghetti L
    Curr Pharm Des; 2006; 12(1):93-109. PubMed ID: 16454728
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression.
    Maggi LB; Sadeghi H; Weigand C; Scarim AL; Heitmeier MR; Corbett JA
    Diabetes; 2000 Mar; 49(3):346-55. PubMed ID: 10868955
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease.
    Takano H; Komuro I
    J Diabetes Complications; 2002; 16(1):108-14. PubMed ID: 11872377
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma.
    Alleva DG; Johnson EB; Lio FM; Boehme SA; Conlon PJ; Crowe PD
    J Leukoc Biol; 2002 Apr; 71(4):677-85. PubMed ID: 11927655
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Clinical Significance of PPAR Gamma Agonism.
    Campbell IW
    Curr Mol Med; 2005 May; 5(3):349-63. PubMed ID: 15892654
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PPAR dual agonists: are they opening Pandora's Box?
    Balakumar P; Rose M; Ganti SS; Krishan P; Singh M
    Pharmacol Res; 2007 Aug; 56(2):91-8. PubMed ID: 17428674
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells.
    Bernardo A; Bianchi D; Magnaghi V; Minghetti L
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):797-808. PubMed ID: 19535992
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation.
    Zhang HL; Gu ZL; Savitz SI; Han F; Fukunaga K; Qin ZH
    J Neurosci Res; 2008 Apr; 86(5):1132-41. PubMed ID: 18074385
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival.
    Wang YL; Frauwirth KA; Rangwala SM; Lazar MA; Thompson CB
    J Biol Chem; 2002 Aug; 277(35):31781-8. PubMed ID: 12082115
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Peroxisome Proliferator-Activated Receptor-Gamma (PPAR-ɣ): Molecular Effects and Its Importance as a Novel Therapeutic Target for Cerebral Ischemic Injury.
    Mannan A; Garg N; Singh TG; Kang HK
    Neurochem Res; 2021 Nov; 46(11):2800-2831. PubMed ID: 34282491
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts.
    Hao GH; Niu XL; Gao DF; Wei J; Wang NP
    Br J Pharmacol; 2008 Apr; 153(7):1409-19. PubMed ID: 18278065
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients.
    Klotz L; Schmidt M; Giese T; Sastre M; Knolle P; Klockgether T; Heneka MT
    J Immunol; 2005 Oct; 175(8):4948-55. PubMed ID: 16210596
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anti-apoptotic actions of PPAR-gamma against ischemic stroke.
    Fong WH; Tsai HD; Chen YC; Wu JS; Lin TN
    Mol Neurobiol; 2010 Jun; 41(2-3):180-6. PubMed ID: 20127524
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Peroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis?
    Pershadsingh HA
    Expert Opin Investig Drugs; 2004 Mar; 13(3):215-28. PubMed ID: 15013941
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PPAR-gamma in ulcerative colitis: a novel target for intervention.
    Bertin B; Dubuquoy L; Colombel JF; Desreumaux P
    Curr Drug Targets; 2013 Nov; 14(12):1501-7. PubMed ID: 23651165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.